{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:39:19Z","timestamp":1793662759700,"version":"4.5.1"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017603","name":"UPES","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017603","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37954-5","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:07:53Z","timestamp":1770386873000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Synergistic combinatorial anticancer potential of Tamoxifen with Naringin and Diosmetin in MCF-7 breast cancer cells and their liposomal delivery"],"prefix":"10.1038","volume":"16","author":[{"given":"Priyanka","family":"Uniyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha","family":"Das Pramanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swadha","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Gaurav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vannajan Sanghiran","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"37954_CR1","unstructured":"Breast cancer. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer"},{"key":"37954_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"37954_CR3","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S1470-2045(21)00071-1","volume":"22","author":"BO Anderson","year":"2021","unstructured":"Anderson, B. O. et al. The global breast cancer initiative: a strategic collaboration to strengthen health care for non-communicable diseases. Lancet Oncol. 22, 578\u2013581 (2021).","journal-title":"Lancet Oncol."},{"key":"37954_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"Cancer J. Clin."},{"key":"37954_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3923\/ijp.2017.785.807","volume":"13","author":"L Villela","year":"2017","unstructured":"Villela, L., Velez, A. K., Lopez-Sanc, R., Mart\u00ednez-Cardona, J. & Hernandez, J. Advantages of drug selective distribution in cancer treatment: Brentuximab Vedotin. Int. J. Pharmacol. 13, 785\u2013807 (2017).","journal-title":"Int. J. Pharmacol."},{"key":"37954_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","volume":"16","author":"A Zafar","year":"2025","unstructured":"Zafar, A., Khatoon, S., Khan, M. J., Abu, J. & Naeem, A. Advancements and limitations in traditional anti-cancer therapies: A comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. Discov. Oncol. 16, 607 (2025).","journal-title":"Discov. Oncol."},{"key":"37954_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.apsb.2015.03.001","volume":"5","author":"L Kang","year":"2015","unstructured":"Kang, L., Gao, Z., Huang, W., Jin, M. & Wang, Q. Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment. Acta Pharm. Sin B. 5, 169\u2013175 (2015).","journal-title":"Acta Pharm. Sin B"},{"key":"37954_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jconrel.2021.06.034","volume":"336","author":"Y Liang","year":"2021","unstructured":"Liang, Y. et al. Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant. J. Controll. Release. 336, 396\u2013409 (2021).","journal-title":"J. Controll. Release"},{"key":"37954_CR9","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.3390\/nano12152672","volume":"12","author":"RD Al Bostami","year":"2022","unstructured":"Al Bostami, R. D., Abuwatfa, W. H. & Husseini, G. A. Recent advances in nanoparticle-based co-delivery systems for cancer therapy. Nanomaterials (Basel). 12, 2672 (2022).","journal-title":"Nanomaterials (Basel)"},{"key":"37954_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1021\/acs.jmedchem.5b01276","volume":"59","author":"R Xiong","year":"2016","unstructured":"Xiong, R. et al. Selective human Estrogen receptor partial agonists (ShERPAs) for Tamoxifen-Resistant breast cancer. J. Med. Chem. 59, 219\u2013237 (2016).","journal-title":"J. Med. Chem."},{"key":"37954_CR11","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3390\/ijms17081357","volume":"17","author":"M Rond\u00f3n-Lagos","year":"2016","unstructured":"Rond\u00f3n-Lagos, M., Villegas, V., Rangel, N., S\u00e1nchez, M. & Zaphiropoulos, P. Tamoxifen resistance: Emerging molecular targets. IJMS 17, 1357 (2016).","journal-title":"IJMS"},{"key":"37954_CR12","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.3390\/cancers12092535","volume":"12","author":"G Emons","year":"2020","unstructured":"Emons, G., Mustea, A. & Tempfer, C. Tamoxifen and endometrial cancer: A Janus-Headed drug. Cancers 12, 2535 (2020).","journal-title":"Cancers"},{"key":"37954_CR13","doi-asserted-by":"publisher","first-page":"1217001","DOI":"10.3389\/fphar.2023.1217001","volume":"14","author":"J He","year":"2023","unstructured":"He, J. & Zhang, H. P. Research progress on the anti-tumor effect of naringin. Front. Pharmacol. 14, 1217001 (2023).","journal-title":"Front. Pharmacol."},{"key":"37954_CR14","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1007\/s00210-024-03672-w","volume":"398","author":"A Alhalmi","year":"2025","unstructured":"Alhalmi, A., Amin, S., Ralli, T., Ali, K. S. & Kohli, K. Therapeutic role of naringin in cancer: molecular pathways, synergy with other agents, and nanocarrier innovations. Naunyn Schmiedebergs Arch. Pharmacol. 398, 3595\u20133615 (2025).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"37954_CR15","doi-asserted-by":"crossref","unstructured":"Ghanbari-Movahed, M., Jackson, G., Farzaei, M. H. & Bishayee, A. A systematic review of the preventive and therapeutic effects of naringin against human malignancies. Front. Pharmacol. 12, 639840 (2021).","DOI":"10.3389\/fphar.2021.639840"},{"key":"37954_CR16","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.12659\/MSM.914058","volume":"25","author":"C Wang","year":"2019","unstructured":"Wang, C. et al. Anti-proliferation and pro-apoptotic effects of Diosmetin via modulating cell cycle arrest and mitochondria-mediated intrinsic apoptotic pathway in MDA-MB-231 cells. Med. Sci. Monit. 25, 4639\u20134647 (2019).","journal-title":"Med. Sci. Monit."},{"key":"37954_CR17","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2174\/0118715206360266250115065234","volume":"25","author":"J Li","year":"2025","unstructured":"Li, J. et al. Effects of citrus-derived Diosmetin on melanoma: Induction of apoptosis andautophagy mediated by PI3K\/Akt\/mTOR pathway inhibition. ACAMC 25, 921\u2013933 (2025).","journal-title":"ACAMC"},{"key":"37954_CR18","first-page":"1741","volume":"40","author":"WJ Shangguan","year":"2017","unstructured":"Shangguan, W. J. et al. Naringin inhibits vascular endothelial cell apoptosis via Endoplasmic reticulum stress\u2013 and mitochondrial\u2013mediated pathways and promotes intraosseous angiogenesis in ovariectomized rats. Int. J. Mol. Med. 40, 1741\u20131749 (2017).","journal-title":"Int. J. Mol. Med."},{"key":"37954_CR19","doi-asserted-by":"publisher","first-page":"7109","DOI":"10.15419\/bmrat.v12i2.955","volume":"12","author":"M Azizpour","year":"2025","unstructured":"Azizpour, M., Changizzadeh, B., Golbashirzadeh, M. & Moradzadegan, A. Exploring the therapeutic potential of naringin and melatonin in breast cancer: A focus on SKBR3 and MCF-7 cell lines. Biomed. Res. Ther. 12, 7109\u20137117 (2025).","journal-title":"Biomed. Res. Ther."},{"key":"37954_CR20","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1021\/acs.molpharmaceut.7b01151","volume":"15","author":"A Roma","year":"2018","unstructured":"Roma, A., Rota, S. G. & Spagnuolo, P. A. Diosmetin induces apoptosis of acute myeloid leukemia cells. Mol. Pharm. 15, 1353\u20131360 (2018).","journal-title":"Mol. Pharm."},{"key":"37954_CR21","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/mc.23774","volume":"63","author":"W Raza","year":"2024","unstructured":"Raza, W., Meena, A. & Luqman, S. Diosmetin: A dietary flavone as modulator of signaling pathways in cancer progression. Mol. Carcinog. 63, 1627\u20131642 (2024).","journal-title":"Mol. Carcinog."},{"key":"37954_CR22","doi-asserted-by":"crossref","unstructured":"Pandey, P. et al. An updated review summarizing the anticancer potential of flavonoids via targeting NF-kB pathway. Front. Pharmacol. 15, 1513422 (2025).","DOI":"10.3389\/fphar.2024.1513422"},{"key":"37954_CR23","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","volume":"8","author":"RB Mokhtari","year":"2017","unstructured":"Mokhtari, R. B. et al. Combination therapy in combating cancer. Oncotarget 8, 38022\u201338043 (2017).","journal-title":"Oncotarget"},{"key":"37954_CR24","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.3390\/cancers14112703","volume":"14","author":"MBA Djamgoz","year":"2022","unstructured":"Djamgoz, M. B. A. Combinatorial therapy of cancer: possible advantages of involving modulators of ionic mechanisms. Cancers (Basel). 14, 2703 (2022).","journal-title":"Cancers (Basel)"},{"key":"37954_CR25","doi-asserted-by":"publisher","first-page":"26881","DOI":"10.1038\/s41598-025-12725-w","volume":"15","author":"C Damodaran","year":"2025","unstructured":"Damodaran, C., Cho, J. Y. & G\u00fcng\u00f6r, C. Therapeutic resistance and combination therapy for cancer: recent developments and future directions. Sci. Rep. 15, 26881 (2025).","journal-title":"Sci. Rep."},{"key":"37954_CR26","doi-asserted-by":"publisher","first-page":"e00149","DOI":"10.1002\/prp2.149","volume":"3","author":"J Foucquier","year":"2015","unstructured":"Foucquier, J. & Guedj, M. Analysis of drug combinations: current methodological landscape. Pharmacol. Res. Perspect. 3, e00149 (2015).","journal-title":"Pharmacol. Res. Perspect."},{"key":"37954_CR27","doi-asserted-by":"publisher","first-page":"173919","DOI":"10.1016\/j.ejphar.2021.173919","volume":"897","author":"V Banerjee","year":"2021","unstructured":"Banerjee, V. et al. Synergistic potential of dual Andrographolide and melatonin targeting of metastatic colon cancer cells: using the Chou-Talalay combination index method. Eur. J. Pharmacol. 897, 173919 (2021).","journal-title":"Eur. J. Pharmacol."},{"key":"37954_CR28","doi-asserted-by":"publisher","first-page":"100110","DOI":"10.1016\/j.crphar.2022.100110","volume":"3","author":"D Duarte","year":"2022","unstructured":"Duarte, D. & Vale, N. Evaluation of synergism in drug combinations and reference models for future orientations in oncology. Curr. Res. Pharmacol. Drug Discov. 3, 100110 (2022).","journal-title":"Curr. Res. Pharmacol. Drug Discov"},{"key":"37954_CR29","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.2147\/IJN.S146315","volume":"12","author":"F Din","year":"2017","unstructured":"Din, F. et al. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int. J. Nanomed. 12, 7291\u20137309 (2017).","journal-title":"Int. J. Nanomed."},{"key":"37954_CR30","first-page":"416","volume":"15","author":"Q He","year":"2020","unstructured":"He, Q. et al. Tumor microenvironment responsive drug delivery systems. Asian J. Pharm. Sci. 15, 416\u2013448 (2020).","journal-title":"Asian J. Pharm. Sci."},{"key":"37954_CR31","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun, L. et al. Smart nanoparticles for cancer therapy. Sig Transduct. Target. Ther. 8, 418 (2023).","journal-title":"Sig Transduct. Target. Ther."},{"key":"37954_CR32","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","volume":"9","author":"D Rosenblum","year":"2018","unstructured":"Rosenblum, D., Joshi, N., Tao, W., Karp, J. M. & Peer, D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat. Commun. 9, 1410 (2018).","journal-title":"Nat. Commun."},{"key":"37954_CR33","doi-asserted-by":"publisher","unstructured":"Deshpande, P. P., Biswas, S. & Torchilin, V. P. Current trends in the use of liposomes for tumor targeting. Nanomed. (Lond). 8, 1509\u20131528 https:\/\/doi.org\/10.2217\/nnm.13.118 (2013).","DOI":"10.2217\/nnm.13.118"},{"key":"37954_CR34","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/pharmaceutics16030400","volume":"16","author":"I Hamad","year":"2024","unstructured":"Hamad, I., Harb, A. A. & Bustanji, Y. Liposome-based drug delivery systems in cancer research: An analysis of global landscape efforts and achievements. Pharmaceutics 16, 400 (2024).","journal-title":"Pharmaceutics"},{"key":"37954_CR35","doi-asserted-by":"publisher","first-page":"3041969","DOI":"10.1155\/2021\/3041969","volume":"2021","author":"L. W. Allahou","year":"2021","unstructured":"Allahou, L. W., Madani, S. Y. & Seifalian, A. Investigating the application of liposomes as drug delivery systems for the diagnosis and treatment of cancer. Int. J. Biomater. 2021, 3041969 (2021).","journal-title":"Int. J. Biomater."},{"key":"37954_CR36","doi-asserted-by":"publisher","first-page":"106688","DOI":"10.1016\/j.ejps.2023.106688","volume":"193","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Recent advances and clinical translation of liposomal delivery systems in cancer therapy. Eur. J. Pharm. Sci. 193, 106688 (2024).","journal-title":"Eur. J. Pharm. Sci."},{"key":"37954_CR37","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1080\/17425247.2024.2394611","volume":"21","author":"F Zahednezhad","year":"2024","unstructured":"Zahednezhad, F. et al. Liposomal drug delivery systems for organ-specific cancer targeting: Early promises, subsequent problems, and recent breakthroughs. Expert Opin. Drug Deliv. 21, 1363\u20131384 (2024).","journal-title":"Expert Opin. Drug Deliv."},{"key":"37954_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/jac\/49.suppl_1.21","volume":"49","author":"J Adler-Moore","year":"2002","unstructured":"Adler-Moore, J., Proffitt, R. T. & AmBisome liposomal formulation, structure, mechanism of action and pre-clinical experience. J. Antimicrob. Chemother. 49, 21\u201330 (2002).","journal-title":"J. Antimicrob. Chemother."},{"key":"37954_CR39","doi-asserted-by":"crossref","unstructured":"Barenholz, Y. (Chezy). Doxil\u00ae\u2014 The first FDA-approved nano-drug: Lessons learned. J. Controll. Release 160, 117\u2013134 (2012).","DOI":"10.1016\/j.jconrel.2012.03.020"},{"key":"37954_CR40","doi-asserted-by":"crossref","unstructured":"Fulton, M. D. & Najahi-Missaoui, W. Liposomes in cancer therapy: How Did we start and where are we now. IJMS 24, 6615 (2023).","DOI":"10.3390\/ijms24076615"},{"key":"37954_CR41","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s10787-018-00556-3","volume":"27","author":"Z Zhao","year":"2019","unstructured":"Zhao, Z., Jin, G., Ge, Y. & Guo, Z. Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways. Inflammopharmacol 27, 1021\u20131036 (2019).","journal-title":"Inflammopharmacol"},{"key":"37954_CR42","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1186\/s12885-021-08641-7","volume":"21","author":"SY Moon","year":"2021","unstructured":"Moon, S. Y. et al. Inhibition of STAT3 enhances sensitivity to Tamoxifen in Tamoxifen-resistant breast cancer cells. BMC Cancer. 21, 931 (2021).","journal-title":"BMC Cancer"},{"key":"37954_CR43","doi-asserted-by":"publisher","first-page":"7489","DOI":"10.1007\/s11033-023-08664-2","volume":"50","author":"M Jalalpour Choupanan","year":"2023","unstructured":"Jalalpour Choupanan, M., Shahbazi, S. & Reiisi, S. Naringenin in combination with quercetin\/fisetin shows synergistic anti-proliferative and migration reduction effects in breast cancer cell lines. Mol. Biol. Rep. 50, 7489\u20137500 (2023).","journal-title":"Mol. Biol. Rep."},{"key":"37954_CR44","doi-asserted-by":"publisher","first-page":"546","DOI":"10.2174\/1573407215666181224105826","volume":"16","author":"M Abdelkarim","year":"2020","unstructured":"Abdelkarim, M. et al. 3,6-dichloro-1,2,4,5-Tetrazine assayed at high doses in the metastatic breast cancer cell line MDA-MB-231 reduces cell numbers and induces apoptosis. Curr. Bioact. Compd. 16, 546\u2013550 (2020).","journal-title":"Curr. Bioact. Compd."},{"key":"37954_CR45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13007-024-01185-4","volume":"20","author":"I Limam","year":"2024","unstructured":"Limam, I. et al. Tunisian Artemisia Campestris L.: A potential therapeutic agent against myeloma\u2014phytochemical and Pharmacological insights. Plant. Methods 20, 59 (2024).","journal-title":"Plant. Methods"},{"key":"37954_CR46","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou, T. C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 70, 440\u2013446 (2010).","journal-title":"Cancer Res."},{"key":"37954_CR47","doi-asserted-by":"publisher","first-page":"BSR20240367","DOI":"10.1042\/BSR20240367","volume":"44","author":"AI Gaballah","year":"2024","unstructured":"Gaballah, A. I. et al. Dexamethasone\u2013tamoxifen combination exerts synergistic therapeutic effects in tamoxifen-resistance breast cancer cells. Biosci. Rep. 44, BSR20240367 (2024).","journal-title":"Biosci. Rep."},{"key":"37954_CR48","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1038\/cddis.2011.12","volume":"2","author":"LU Ling","year":"2011","unstructured":"Ling, L. U., Tan, K. B., Lin, H. & Chiu, G. N. C. The role of reactive oxygen species and autophagy in safingol-induced cell death. Cell. Death Dis. 2, e129\u2013e129 (2011).","journal-title":"Cell. Death Dis."},{"key":"37954_CR49","doi-asserted-by":"publisher","first-page":"15031","DOI":"10.1039\/D0NJ02588G","volume":"44","author":"S Shyamsivappan","year":"2020","unstructured":"Shyamsivappan, S. et al. Novel phenyl and thiophene dispiro indenoquinoxaline pyrrolidine quinolones induced apoptosis via G1\/S and G2\/M phase cell cycle arrest in MCF-7 cells. New. J. Chem. 44, 15031\u201315045 (2020).","journal-title":"New. J. Chem."},{"key":"37954_CR50","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3390\/cells10071659","volume":"10","author":"C Alcon","year":"2021","unstructured":"Alcon, C. et al. ER+ breast cancer strongly depends on MCL-1 and BCL-xL anti-apoptotic proteins. Cells 10, 1659 (2021).","journal-title":"Cells"},{"key":"37954_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1081\/LPR-100103174","volume":"11","author":"Y Maitani","year":"2001","unstructured":"Maitani, Y., Soeda, H., Junping, W. & Takayama, K. Modified ethanol injection method for liposomes containing \u03b2-sitosterol \u03b2-D-glucoside. J. Liposome Res. 11, 115\u2013125 (2001).","journal-title":"J. Liposome Res."},{"key":"37954_CR52","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/CAD.0b013e328336e940","volume":"21","author":"MY Wong","year":"2010","unstructured":"Wong, M. Y. & Chiu, G. N. C. Simultaneous liposomal delivery of quercetin and vincristine for enhanced estrogen-receptor-negative breast cancer treatment. Anti-Cancer Drugs. 21, 401\u2013410 (2010).","journal-title":"Anti-Cancer Drugs"},{"key":"37954_CR53","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3390\/polym13020250","volume":"13","author":"P Kesharwani","year":"2021","unstructured":"Kesharwani, P., Md, S., Alhakamy, N. A., Hosny, K. M. & Haque, A. QbD enabled Azacitidine loaded liposomal nanoformulation and its in vitro evaluation. Polymers 13, 250 (2021).","journal-title":"Polymers"},{"key":"37954_CR54","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.saa.2015.03.095","volume":"147","author":"AS Saad","year":"2015","unstructured":"Saad, A. S. Novel spectrophotometric method for selective determination of compounds in ternary mixtures (dual wavelength in ratio spectra). Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 147, 257\u2013261 (2015).","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"37954_CR55","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/9781118971147.ch5","volume-title":"ICH Quality Guidelines","author":"P Borman","year":"2017","unstructured":"Borman, P., Elder, D. & Q2(R1. ) Validation of analytical procedures. In ICH Quality Guidelines 127\u2013166 (John Wiley & Sons, Ltd, 2017). https:\/\/doi.org\/10.1002\/9781118971147.ch5"},{"key":"37954_CR56","doi-asserted-by":"publisher","first-page":"106267","DOI":"10.1016\/j.ejps.2022.106267","volume":"177","author":"AM Hols\u00e6ter","year":"2022","unstructured":"Hols\u00e6ter, A. M. et al. How docetaxel entrapment, vesicle size, zeta potential and stability change with liposome composition\u2013A formulation screening study. Eur. J. Pharm. Sci. 177, 106267 (2022).","journal-title":"Eur. J. Pharm. Sci."},{"key":"37954_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fbio.2016.04.005","volume":"15","author":"C Sebaaly","year":"2016","unstructured":"Sebaaly, C., Greige-Gerges, H., Stainmesse, S., Fessi, H. & Charcosset, C. Effect of composition, hydrogenation of phospholipids and lyophilization on the characteristics of eugenol-loaded liposomes prepared by ethanol injection method. Food Biosci. 15, 1\u201310 (2016).","journal-title":"Food Biosci."},{"key":"37954_CR58","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.nano.2017.03.003","volume":"13","author":"PS Sandhu","year":"2017","unstructured":"Sandhu, P. S. et al. Natural lipids enriched self-nano-emulsifying systems for effective co-delivery of Tamoxifen and naringenin: systematic approach for improved breast cancer therapeutics. Nanomed. Nanotechnol. Biol. Med. 13, 1703\u20131713 (2017).","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"37954_CR59","doi-asserted-by":"publisher","first-page":"103091","DOI":"10.1016\/j.pdpdt.2022.103091","volume":"40","author":"E Prathyusha","year":"2022","unstructured":"Prathyusha, E. et al. Investigation of ROS generating capacity of curcumin-loaded liposomes and its in vitro cytotoxicity on MCF-7 cell lines using photodynamic therapy. Photodiagn. Photodyn. Ther. 40, 103091 (2022).","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"37954_CR60","doi-asserted-by":"publisher","first-page":"888802","DOI":"10.3389\/fendo.2022.888802","volume":"13","author":"RHG Wright","year":"2022","unstructured":"Wright, R. H. G., Vastolo, V., Oliete, J. Q., Carbonell-Caballero, J. & Beato, M. Global signalling network analysis of luminal T47D breast cancer cells in response to progesterone. Front. Endocrinol. (Lausanne). 13, 888802 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"37954_CR61","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.3390\/molecules29153531","volume":"29","author":"J P\u0142onka-Czerw","year":"2024","unstructured":"P\u0142onka-Czerw, J., \u017byrek, L. & Latocha, M. Changes in the sensitivity of MCF-7 and MCF-7\/DX breast cancer cells to cytostatic in the presence of Metformin. Molecules 29, 3531 (2024).","journal-title":"Molecules"},{"key":"37954_CR62","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/sj.bjc.6602955","volume":"94","author":"S Matsuyoshi","year":"2006","unstructured":"Matsuyoshi, S., Shimada, K., Nakamura, M. & Ishida, E. Konishi, N. FADD phosphorylation is critical for cell cycle regulation in breast cancer cells. Br. J. Cancer. 94, 532\u2013539 (2006).","journal-title":"Br. J. Cancer"},{"key":"37954_CR63","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/ph15030314","volume":"15","author":"M Kalabay","year":"2022","unstructured":"Kalabay, M. et al. Investigation of the antitumor effects of Tamoxifen and its ferrocene-linked derivatives on pancreatic and breast cancer cell lines. Pharmaceuticals (Basel). 15, 314 (2022).","journal-title":"Pharmaceuticals (Basel)"},{"key":"37954_CR64","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.1002\/tox.24378","volume":"39","author":"CH Chen","year":"2024","unstructured":"Chen, C. H. et al. Naringin induces ROS-stimulated G1 cell-cycle arrest and apoptosis in nasopharyngeal carcinoma cells. Environ. Toxicol. 39, 5059\u20135073 (2024).","journal-title":"Environ. Toxicol."},{"key":"37954_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2016.04.023","volume":"153","author":"A Ge","year":"2016","unstructured":"Ge, A. et al. Diosmetin prevents TGF-\u03b21-induced epithelial-mesenchymal transition via ROS\/MAPK signaling pathways. Life Sci. 153, 1\u20138 (2016).","journal-title":"Life Sci."},{"key":"37954_CR66","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/biom13010093","volume":"13","author":"Y Yuan","year":"2023","unstructured":"Yuan, Y., Long, H., Zhou, Z., Fu, Y. & Jiang, B. PI3K-AKT-targeting breast cancer treatments: Natural products and synthetic compounds. Biomolecules 13, 93 (2023).","journal-title":"Biomolecules"},{"key":"37954_CR67","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12032-023-02180-w","volume":"40","author":"Z Pan","year":"2023","unstructured":"Pan, Z. et al. Diosmetin induces apoptosis and protective autophagy in human gastric cancer HGC-27 cells via the PI3K\/Akt\/FoxO1 and MAPK\/JNK pathways. Med. Oncol. 40, 319 (2023).","journal-title":"Med. Oncol."},{"key":"37954_CR68","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12885-022-09446-y","volume":"22","author":"HJ Lee","year":"2022","unstructured":"Lee, H. J. & Choi, C. H. Characterization of SN38-resistant T47D breast cancer cell sublines overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4. BMC Cancer. 22, 446 (2022).","journal-title":"BMC Cancer"},{"key":"37954_CR69","doi-asserted-by":"publisher","first-page":"112526","DOI":"10.1016\/j.biopha.2021.112526","volume":"146","author":"P Farhadi","year":"2022","unstructured":"Farhadi, P. et al. Cell line-directed breast cancer research based on glucose metabolism status. Biomed. Pharmacother. 146, 112526 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"37954_CR70","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.synres.2018.04.001","volume":"7","author":"TC Chou","year":"2018","unstructured":"Chou, T. C. The combination index (CI\u2009<\u20091) as the definition of synergism and of synergy claims. Synergy 7, 49\u201350 (2018).","journal-title":"Synergy"},{"key":"37954_CR71","doi-asserted-by":"publisher","first-page":"19431","DOI":"10.1038\/s41598-025-03242-x","volume":"15","author":"FN Kalkan","year":"2025","unstructured":"Kalkan, F. N. et al. Synergistic and antagonistic drug interactions are prevalent but not conserved across acute myeloid leukemia cell lines. Sci. Rep. 15, 19431 (2025).","journal-title":"Sci. Rep."},{"key":"37954_CR72","doi-asserted-by":"publisher","unstructured":"Benderski, K., Lammers, T. & Sofias, A. M. Analysis of multi-drug cancer nanomedicine. Nat. Nanotechnol. https:\/\/doi.org\/10.1038\/s41565-025-01932-1 (2025).","DOI":"10.1038\/s41565-025-01932-1"},{"key":"37954_CR73","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41597-024-02915-y","volume":"11","author":"C Hu","year":"2024","unstructured":"Hu, C. et al. Optimizing drug combination and mechanism analysis based on risk pathway crosstalk in pan cancer. Sci. Data 11, 74 (2024).","journal-title":"Sci. Data"},{"key":"37954_CR74","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12672-021-00411-y","volume":"12","author":"NS Ahmed","year":"2021","unstructured":"Ahmed, N. S., Samec, M., Liskova, A., Kubatka, P. & Saso, L. Tamoxifen and oxidative stress: An overlooked connection. Discov. Oncol. 12, 17 (2021).","journal-title":"Discov. Oncol."},{"key":"37954_CR75","doi-asserted-by":"publisher","first-page":"100108","DOI":"10.1016\/j.cstres.2025.100108","volume":"30","author":"D. Tan","year":"2025","unstructured":"Tan, D., Ma, N., Wang, Y., Li, X. & Xu, M. Reactive oxygen species in cancer: mechanistic insights and therapeutic innovations. Cell. Stress Chaperones 30, 100108 https:\/\/doi.org\/10.1016\/j.cstres.2025.100108 (2025).","journal-title":"Cell. Stress Chaperones"},{"key":"37954_CR76","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.1038\/s41598-021-86599-z","volume":"11","author":"DM El-Kersh","year":"2021","unstructured":"El-Kersh, D. M. et al. Anti-estrogenic and anti-aromatase activities of citrus peels major compounds in breast cancer. Sci. Rep. 11, 7121 (2021).","journal-title":"Sci. Rep."},{"key":"37954_CR77","doi-asserted-by":"publisher","first-page":"e70107","DOI":"10.1002\/ddr.70107","volume":"86","author":"R Tiwari","year":"2025","unstructured":"Tiwari, R. et al. Reactive oxygen species (ROS) and their profound influence on regulating diverse aspects of cancer: A concise review. Drug Dev. Res. 86, e70107 (2025).","journal-title":"Drug Dev. Res."},{"key":"37954_CR78","doi-asserted-by":"crossref","unstructured":"Yuan, L. et al. Promoting apoptosis, a promising way to treat breast cancer with natural products: A comprehensive review. Front. Pharmacol. 12, 801662 (2022).","DOI":"10.3389\/fphar.2021.801662"},{"key":"37954_CR79","doi-asserted-by":"publisher","first-page":"8189","DOI":"10.1007\/s00210-025-03876-8","volume":"398","author":"BK Utpal","year":"2025","unstructured":"Utpal, B. K. et al. Exploring natural products as apoptosis modulators in cancers: insights into natural product-based therapeutic strategies. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 398, 8189\u20138214 (2025).","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"37954_CR80","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1017\/jns.2016.41","volume":"5","author":"AN Panche","year":"2016","unstructured":"Panche, A. N., Diwan, A. D. & Chandra, S. R. Flavonoids: An overview. J. Nutr. Sci. 5, e47 (2016).","journal-title":"J. Nutr. Sci."},{"key":"37954_CR81","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.3390\/molecules28083475","volume":"28","author":"M Imran","year":"2023","unstructured":"Imran, M. et al. Exploring the remarkable chemotherapeutic potential of polyphenolic antioxidants in battling various forms of cancer. Molecules 28, 3475 (2023).","journal-title":"Molecules"},{"key":"37954_CR82","doi-asserted-by":"publisher","first-page":"1431085","DOI":"10.3389\/fphar.2024.1431085","volume":"15","author":"P. Bisht","year":"2024","unstructured":"Bisht, P. et al. Naringin and Temozolomide combination suppressed the growth of glioblastoma cells by promoting cell apoptosis: Network pharmacology, in-vitro assays and metabolomics based study. Front. Pharmacol. 15, 1431085 (2024).","journal-title":"Front. Pharmacol."},{"key":"37954_CR83","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1158\/1078-0432.CCR-08-0144","volume":"15","author":"MH Kang","year":"2009","unstructured":"Kang, M. H. & Reynolds, C. P. Bcl-2 inhibitors: Targeting mitochondrial apoptotic pathways in cancer therapy. Clin. Cancer Res. 15, 1126\u20131132 (2009).","journal-title":"Clin. Cancer Res."},{"key":"37954_CR84","doi-asserted-by":"publisher","first-page":"111826","DOI":"10.1016\/j.celrep.2022.111826","volume":"41","author":"V Bharti","year":"2022","unstructured":"Bharti, V. et al. BCL-xL Inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis. Cell. Rep. 41, 111826 (2022).","journal-title":"Cell. Rep."},{"key":"37954_CR85","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.prnil.2017.11.001","volume":"6","author":"S Erdogan","year":"2018","unstructured":"Erdogan, S., Doganlar, O., Doganlar, Z. B. & Turkekul, K. Naringin sensitizes human prostate cancer cells to paclitaxel therapy. Prostate Int. 6, 126\u2013135 (2018).","journal-title":"Prostate Int."},{"key":"37954_CR86","doi-asserted-by":"publisher","first-page":"574496","DOI":"10.3389\/fphar.2020.574496","volume":"11","author":"P. K. Ajji","year":"2020","unstructured":"Ajji, P. K., Walder, K. & Puri, M. Combination of balsamin and flavonoids induce apoptotic effects in liver and breast cancer cells. Front. Pharmacol. 11, 574496 (2020).","journal-title":"Front. Pharmacol."},{"key":"37954_CR87","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2133\/dmpk.DMPK-11-RG-048","volume":"26","author":"L Quintieri","year":"2011","unstructured":"Quintieri, L., Palatini, P., Moro, S. & Floreani, M. Inhibition of cytochrome P450 2C8-mediated drug metabolism by the flavonoid Diosmetin. Drug Metab. Pharmacokinet. 26, 559\u2013568 (2011).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"37954_CR88","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1038\/s41598-024-53320-9","volume":"14","author":"H Effat","year":"2024","unstructured":"Effat, H., Abosharaf, H. A. & Radwan, A. M. Combined effects of naringin and doxorubicin on the JAK\/STAT signaling pathway reduce the development and spread of breast cancer cells. Sci. Rep. 14, 2824 (2024).","journal-title":"Sci. Rep."},{"key":"37954_CR89","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/iub.2476","volume":"73","author":"H Kim","year":"2021","unstructured":"Kim, H. & Lee, D. G. Naringin-generated ROS promotes mitochondria-mediated apoptosis in Candida albicans. IUBMB Life. 73, 953\u2013967 (2021).","journal-title":"IUBMB Life"},{"key":"37954_CR90","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.3390\/ijms22094699","volume":"22","author":"P Crosley","year":"2021","unstructured":"Crosley, P. et al. Procaspase-activating compound-1 synergizes with TRAIL to induce apoptosis in established granulosa cell tumor cell line (KGN) and explanted patient granulosa cell tumor cells in vitro. Int. J. Mol. Sci. 22, 4699 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"37954_CR91","doi-asserted-by":"publisher","first-page":"41","DOI":"10.31557\/apjcb.2017.2.2.41-49","volume":"2","author":"M Abachi","year":"2017","unstructured":"Abachi, M., Salati, M., Araghi, S., Shirkoohi, R. & Eslamifar, A. Molecular analysis of acquired Tamoxifen resistance in breast cancer cell line. Asian Pac. J. Cancer Biology. 2, 41\u201349 (2017).","journal-title":"Asian Pac. J. Cancer Biology"},{"key":"37954_CR92","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41419-017-0072-x","volume":"9","author":"MM Williams","year":"2018","unstructured":"Williams, M. M. et al. Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers. Cell. Death Dis. 9, 21 (2018).","journal-title":"Cell. Death Dis."},{"key":"37954_CR93","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10528-020-09996-5","volume":"59","author":"D Albayrak","year":"2021","unstructured":"Albayrak, D. et al. Naringin combined with NF-\u03baB Inhibition and Endoplasmic reticulum stress induces apoptotic cell death via oxidative stress and the PERK\/eIF2\u03b1\/ATF4\/CHOP axis in HT29 colon cancer cells. Biochem. Genet. 59, 159\u2013184 (2021).","journal-title":"Biochem. Genet."},{"key":"37954_CR94","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3892\/mmr.2021.12412","volume":"24","author":"C Xu","year":"2021","unstructured":"Xu, C. et al. Naringin induces apoptosis of gastric carcinoma cells via blocking the PI3K\/AKT pathway and activating pro\u2013death autophagy. Mol. Med. Rep. 24, 772 (2021).","journal-title":"Mol. Med. Rep."},{"key":"37954_CR95","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.3892\/ol.2016.5347","volume":"12","author":"J Qiao","year":"2016","unstructured":"Qiao, J. et al. Diosmetin triggers cell apoptosis by activation of the p53\/Bcl-2 pathway and inactivation of the Notch3\/NF-\u03baB pathway in HepG2 cells. Oncol. Lett. 12, 5122\u20135128 (2016).","journal-title":"Oncol. Lett."},{"key":"37954_CR96","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40659-021-00363-1","volume":"54","author":"R Ning","year":"2021","unstructured":"Ning, R. et al. Diosmetin inhibits cell proliferation and promotes apoptosis through STAT3\/c-Myc signaling pathway in human osteosarcoma cells. Biol. Res. 54, 40 (2021).","journal-title":"Biol. Res."},{"key":"37954_CR97","doi-asserted-by":"publisher","first-page":"102174","DOI":"10.1016\/j.jddst.2020.102174","volume":"61","author":"A Gouda","year":"2021","unstructured":"Gouda, A., Sakr, O. S., Nasr, M. & Sammour, O. Ethanol injection technique for liposomes formulation: An insight into development, influencing factors, challenges and applications. J. Drug Deliv. Sci. Technol. 61, 102174 (2021).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"37954_CR98","doi-asserted-by":"publisher","first-page":"124641","DOI":"10.1016\/j.ijpharm.2024.124641","volume":"664","author":"A Pittiu","year":"2024","unstructured":"Pittiu, A. et al. Production of liposomes by microfluidics: the impact of post-manufacturing dilution on drug encapsulation and lipid loss. Int. J. Pharm. 664, 124641 (2024).","journal-title":"Int. J. Pharm."},{"key":"37954_CR99","doi-asserted-by":"publisher","first-page":"109677","DOI":"10.1016\/j.cep.2024.109677","volume":"196","author":"X Qi","year":"2024","unstructured":"Qi, X., Wang, J., Chen, C. & Wang, L. Optimal design of micromixer for preparation of nanoliposomes. Chem. Eng. Process. Process. Intensif. 196, 109677 (2024).","journal-title":"Chem. Eng. Process. - Process. Intensif."},{"key":"37954_CR100","doi-asserted-by":"publisher","first-page":"25876","DOI":"10.1038\/srep25876","volume":"6","author":"D Carugo","year":"2016","unstructured":"Carugo, D., Bottaro, E., Owen, J., Stride, E. & Nastruzzi, C. Liposome production by microfluidics: Potential and limiting factors. Sci. Rep. 6, 25876 (2016).","journal-title":"Sci. Rep."},{"key":"37954_CR101","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1021\/jf205260g","volume":"60","author":"G Zhang","year":"2012","unstructured":"Zhang, G., Wang, L. & Pan, J. Probing the binding of the flavonoid Diosmetin to human serum albumin by multispectroscopic techniques. J. Agric. Food Chem. 60, 2721\u20132729 (2012).","journal-title":"J. Agric. Food Chem."},{"key":"37954_CR102","first-page":"299","volume":"10","author":"A Hakim","year":"2019","unstructured":"Hakim, A., Loka, I. & Prastiwi, N. New method for isolation of naringin compound from citrus maxima. Nat. Resour. 10, 299\u2013304 (2019).","journal-title":"Nat. Resour."},{"key":"37954_CR103","doi-asserted-by":"publisher","first-page":"25808","DOI":"10.1021\/acsomega.3c00844","volume":"8","author":"Z Khan","year":"2023","unstructured":"Khan, Z. et al. Preparation and in vitro evaluation of Tamoxifen-conjugated, eco-friendly, agar-based hybrid magnetic nanoparticles for their potential use in breast cancer treatment. ACS Omega. 8, 25808\u201325816 (2023).","journal-title":"ACS Omega"},{"key":"37954_CR104","doi-asserted-by":"publisher","unstructured":"Gupta, S. R. N. Determination of lecithin from egg yolk, milk, Soyabean seed, sunflower oil calorimetrically and its FTIR study (2024). https:\/\/doi.org\/10.5281\/ZENODO.12702228","DOI":"10.5281\/ZENODO.12702228"},{"key":"37954_CR105","doi-asserted-by":"publisher","first-page":"124879","DOI":"10.1016\/j.molliq.2024.124879","volume":"403","author":"E Romano","year":"2024","unstructured":"Romano, E. et al. Identification of cholesterol in different media by using the FT-IR, FT-Raman and UV\u2013visible spectra combined with DFT calculations. J. Mol. Liq. 403, 124879 (2024).","journal-title":"J. Mol. Liq."},{"key":"37954_CR106","doi-asserted-by":"publisher","first-page":"102406","DOI":"10.1016\/j.jddst.2021.102406","volume":"62","author":"S Mohebbi","year":"2021","unstructured":"Mohebbi, S., Shariatipour, M., Shafie, B. & Amini, M. M. Encapsulation of Tamoxifen citrate in functionalized mesoporous silica and investigation of its release. J. Drug Deliv. Sci. Technol. 62, 102406 (2021).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"37954_CR107","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.str.2021.01.004","volume":"29","author":"GJ Taghon","year":"2021","unstructured":"Taghon, G. J., Rowe, J. B., Kapolka, N. J. & Isom, D. G. Predictable cholesterol binding sites in GPCRs lack consensus motifs. Structure 29, 499\u2013506e3 (2021).","journal-title":"Structure"},{"key":"37954_CR108","first-page":"117","volume":"15","author":"R Chaki","year":"2025","unstructured":"Chaki, R. et al. Biocompatible nanocarriers of bioactive flavonoid naringin: Design, formulation, and comprehensive characterization. J. App Pharm. Sci. 15, 117\u2013126 (2025).","journal-title":"J. App Pharm. Sci."},{"key":"37954_CR109","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jmst.2024.06.001","volume":"211","author":"D Xie","year":"2025","unstructured":"Xie, D. et al. Convenient and highly efficient adsorption of Diosmetin from lemon peel by magnetic surface molecularly imprinted polymers. J. Mater. Sci. Technol. 211, 159\u2013170 (2025).","journal-title":"J. Mater. Sci. Technol."},{"key":"37954_CR110","first-page":"100059","volume":"5","author":"EG Halevas","year":"2022","unstructured":"Halevas, E. G., Avgoulas, D. I., Katsipis, G. & Pantazaki, A. A. Flavonoid-liposomes formulations: Physico-chemical characteristics, biological activities and therapeutic applications. Eur. J. Med. Chem. Rep. 5, 100059 (2022).","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"37954_CR111","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","volume":"3","author":"M Mehta","year":"2023","unstructured":"Mehta, M. et al. Lipid-based nanoparticles for drug\/gene delivery: An overview of the production techniques and difficulties encountered in their industrial development. ACS Mater. Au. 3, 600\u2013619 (2023).","journal-title":"ACS Mater. Au"},{"key":"37954_CR112","doi-asserted-by":"publisher","first-page":"104642","DOI":"10.1016\/j.jddst.2023.104642","volume":"86","author":"A Sani","year":"2023","unstructured":"Sani, A. et al. Revolutionizing anticancer drug delivery: Exploring the potential of tamoxifen-loaded nanoformulations. J. Drug Deliv. Sci. Technol. 86, 104642 (2023).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"37954_CR113","doi-asserted-by":"publisher","first-page":"15764","DOI":"10.3390\/ijms242115764","volume":"24","author":"R Ashfaq","year":"2023","unstructured":"Ashfaq, R. et al. Lipid nanoparticles: an effective tool to improve the bioavailability of nutraceuticals. Int. J. Mol. Sci. 24, 15764 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"37954_CR114","doi-asserted-by":"publisher","first-page":"16701","DOI":"10.1021\/acsomega.0c01582","volume":"5","author":"G Midekessa","year":"2020","unstructured":"Midekessa, G. et al. Zeta potential of extracellular vesicles: Toward understanding the attributes that determine colloidal stability. ACS Omega. 5, 16701\u201316710 (2020).","journal-title":"ACS Omega"},{"key":"37954_CR115","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.3390\/pharmaceutics14091798","volume":"14","author":"Z N\u00e9meth","year":"2022","unstructured":"N\u00e9meth, Z. et al. Quality by Design-Driven zeta potential optimisation study of liposomes with charge imparting membrane additives. Pharmaceutics 14, 1798 (2022).","journal-title":"Pharmaceutics"},{"key":"37954_CR116","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.micron.2006.08.003","volume":"38","author":"SB Rizwan","year":"2007","unstructured":"Rizwan, S. B., Dong, Y. D., Boyd, B. J., Rades, T. & Hook, S. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM). Micron 38, 478\u2013485 (2007).","journal-title":"Micron"},{"key":"37954_CR117","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.foodchem.2014.01.115","volume":"156","author":"A Rashidinejad","year":"2014","unstructured":"Rashidinejad, A., Birch, E. J., Sun-Waterhouse, D. & Everett, D. W. Delivery of green tea catechin and epigallocatechin gallate in liposomes incorporated into low-fat hard cheese. Food Chem. 156, 176\u2013183 (2014).","journal-title":"Food Chem."},{"key":"37954_CR118","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.3390\/pharmaceutics15122685","volume":"15","author":"H \u015eahin Bektay","year":"2023","unstructured":"\u015eahin Bektay, H., Sa\u011f\u0131ro\u011flu, A. A., Bozali, K., G\u00fcler, E. M. & G\u00fcng\u00f6r, S. The design and optimization of ceramide NP-loaded liposomes to restore the skin barrier. Pharmaceutics 15, 2685 (2023).","journal-title":"Pharmaceutics"},{"key":"37954_CR119","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3390\/pharmaceutics16121525","volume":"16","author":"IL Dejeu","year":"2024","unstructured":"Dejeu, I. L. et al. Innovative approaches to enhancing the biomedical properties of liposomes. Pharmaceutics 16, 1525 (2024).","journal-title":"Pharmaceutics"},{"key":"37954_CR120","doi-asserted-by":"publisher","unstructured":"Lee, Y. & Thompson, D. H. Stimuli-Responsive liposomes for drug delivery. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 9 https:\/\/doi.org\/10.1002\/wnan.1450 (2017).","DOI":"10.1002\/wnan.1450"},{"key":"37954_CR121","doi-asserted-by":"publisher","first-page":"101875","DOI":"10.1016\/j.cocis.2024.101875","volume":"75","author":"R Eugster","year":"2025","unstructured":"Eugster, R., Luciani, P. & Liposomes Bridging the gap from lab to pharmaceuticals. Curr. Opin. Colloid Interface Sci. 75, 101875 (2025).","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"37954_CR122","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.3390\/mi13101623","volume":"13","author":"X Bai","year":"2022","unstructured":"Bai, X., Smith, Z. L., Wang, Y., Butterworth, S. & Tirella, A. Sustained drug release from smart nanoparticles in cancer therapy: A comprehensive review. Micromachines (Basel). 13, 1623 (2022).","journal-title":"Micromachines (Basel)"},{"key":"37954_CR123","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/pharmaceutics11030140","volume":"11","author":"C Mircioiu","year":"2019","unstructured":"Mircioiu, C. et al. Mathematical modeling of release kinetics from supramolecular drug delivery systems. Pharmaceutics 11, 140 (2019).","journal-title":"Pharmaceutics"},{"key":"37954_CR124","doi-asserted-by":"publisher","unstructured":"Ahmadzadegan, A., Zhang, J., Ardekani, A. & Vlachos, P. Spatiotemporal Measurement of Concentration-Dependent Diffusion Coefficient. (2022). https:\/\/doi.org\/10.22541\/au.164873358.86144442\/v1","DOI":"10.22541\/au.164873358.86144442\/v1"},{"key":"37954_CR125","unstructured":"Ahmed, L. et al. Study the using of nanoparticles as drug delivery system based on mathematical models for controlled release. IJLTEMAS 8, 52\u201356 (2019)."},{"key":"37954_CR126","doi-asserted-by":"crossref","unstructured":"Askarizadeh, M., Esfandiari, N., Honarvar, B., Sajadian, S. A. & Azdarpour, A. Kinetic modeling to explain the release of medicine from drug delivery systems. ChemBioEng Rev. 10, 1006\u20131049 (2023).","DOI":"10.1002\/cben.202300027"},{"key":"37954_CR127","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1109\/TNB.2021.3097909","volume":"20","author":"NA Sawaftah","year":"2021","unstructured":"Sawaftah, N. A., Paul, V., Awad, N. & Husseini, G. A. Modeling of Anti-Cancer drug release kinetics from liposomes and micelles: A review. IEEE Trans. Nanobiosci. 20, 565\u2013576 (2021).","journal-title":"IEEE Trans. Nanobiosci."},{"key":"37954_CR128","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.3390\/biomedicines10123139","volume":"10","author":"Z AlMajed","year":"2022","unstructured":"AlMajed, Z., Salkho, N. M., Sulieman, H. & Husseini, G. A. Modeling of the in vitro release kinetics of sonosensitive targeted liposomes. Biomedicines 10, 3139 (2022).","journal-title":"Biomedicines"},{"key":"37954_CR129","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2147\/IJN.S488961","volume":"20","author":"Z Izadiyan","year":"2025","unstructured":"Izadiyan, Z. et al. Advancements in liposomal nanomedicines: innovative formulations, therapeutic applications, and future directions in precision medicine. Int. J. Nanomed. 20, 1213\u20131262 (2025).","journal-title":"Int. J. Nanomed."},{"key":"37954_CR130","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/pharmaceutics17020276","volume":"17","author":"A Kozak","year":"2025","unstructured":"Kozak, A., Lavrih, E., Mikhaylov, G. & Turk, B. Vasiljeva, O. Navigating the clinical landscape of liposomal therapeutics in cancer treatment. Pharmaceutics 17, 276 (2025).","journal-title":"Pharmaceutics"},{"key":"37954_CR131","doi-asserted-by":"publisher","first-page":"140","DOI":"10.54254\/2753-8818\/2025.19713","volume":"69","author":"D Xiao","year":"2025","unstructured":"Xiao, D. (Zoe) Liposomal drug delivery: comparative kinetics, efficacy, and applications in targeted therapeutics. Theor. Nat. Sci. 69, 140\u2013149 (2025).","journal-title":"Theor. Nat. Sci."},{"key":"37954_CR132","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3390\/ph15111431","volume":"15","author":"M Farhan","year":"2022","unstructured":"Farhan, M. Naringin\u2019s prooxidant effect on tumor cells: Copper\u2019s role and therapeutic implications. Pharmaceuticals (Basel). 15, 1431 (2022).","journal-title":"Pharmaceuticals (Basel)"},{"key":"37954_CR133","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s13058-014-0431-9","volume":"16","author":"CY Liu","year":"2014","unstructured":"Liu, C. Y. et al. Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A\u2013dependent phospho-Akt inactivation in Estrogen receptor\u2013negative human breast cancer cells. Breast Cancer Res. 16, 431 (2014).","journal-title":"Breast Cancer Res."},{"key":"37954_CR134","doi-asserted-by":"publisher","first-page":"5148","DOI":"10.1038\/s41598-019-41685-1","volume":"9","author":"S Koosha","year":"2019","unstructured":"Koosha, S., Mohamed, Z., Sinniah, A. & Alshawsh, M. A. Investigation into the molecular mechanisms underlying the Anti-proliferative and anti-tumorigenesis activities of Diosmetin against HCT-116 human colorectal cancer. Sci. Rep. 9, 5148 (2019).","journal-title":"Sci. Rep."},{"key":"37954_CR135","doi-asserted-by":"publisher","first-page":"847113","DOI":"10.3389\/fphar.2022.847113","volume":"13","author":"C. Yen","year":"2022","unstructured":"Yen, C., Zhao, F., Yu, Z., Zhu, X. & Li, C. G. Interactions between natural products and Tamoxifen in breast cancer: A comprehensive literature review. Front. Pharmacol. 13, 847113 (2022).","journal-title":"Front. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37954-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37954-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37954-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T11:03:42Z","timestamp":1772017422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37954-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":135,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37954"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37954-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"25 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7646"}}